Literature DB >> 15381285

Neuronal localization and association of Niemann Pick C2 protein (HE1/NPC2) with the postsynaptic density.

W Y Ong1, R K Sundaram, E Huang, S Ghoshal, U Kumar, P G Pentchev, S C Patel.   

Abstract

Niemann-Pick disease type C (NP-C) is an inherited disorder that is characterized biochemically by cellular cholesterol and glycolipid storage, and clinically by progressive neurodegeneration. Most cases of NP-C are caused by inactivating mutations of the npc1 gene, but about 5% are linked to npc2, which encodes a soluble cholesterol binding protein, previously identified as epididymal secretory glycoprotein 1 (HE1). The present study was carried out to investigate the immunocytochemical localization of HE1/NPC2 protein in the mouse brain. Using an antibody against recombinant HE1/NPC2, we found HE1/NPC2 to be localized predominantly in neurons in the brain. Immunoreactivity for HE1/NPC2 was observed in pyramidal or projection neurons in the cerebral cortex and amygdala, and Purkinje neurons in the cerebellum. Neurons in the thalamus, hypothalamus, and globus pallidus were lightly labeled, or unlabeled. This regional pattern of expression of HE1/NPC2 is similar to our previous findings with NPC1, with a low level of expression of both NPC1 and HE1/NPC2 proteins in regions derived from the diencephalon, such as the thalamus and hypothalamus. In contrast to NPC1, however, which is predominantly in astrocytes, HE1/NPC2 was observed mainly in neurons. Electron microscopic immunocytochemistry showed that HE1/NPC2 is present in the cytosol of dendrites and on post-synaptic densities (PSD). The occurrence of HE1/NPC2 in the PSD was confirmed by Western blots of PSD-enriched brain subcellular fractions that showed the presence of HE1/NPC2 together with the PSD-associated protein, PSD-95. These results suggest that NPC1 and HE1/NPC2 are differentially enriched in astrocytes and neurons, respectively, and that HE1/NPC2 may function in supporting the integrity of the PSD of neurons.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15381285     DOI: 10.1016/j.neuroscience.2004.07.001

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  9 in total

1.  Quantitative Proteome Analysis of Mouse Liver Lysosomes Provides Evidence for Mannose 6-phosphate-independent Targeting Mechanisms of Acid Hydrolases in Mucolipidosis II.

Authors:  Sandra Markmann; Svenja Krambeck; Christopher J Hughes; Mina Mirzaian; Johannes M F G Aerts; Paul Saftig; Michaela Schweizer; Johannes P C Vissers; Thomas Braulke; Markus Damme
Journal:  Mol Cell Proteomics       Date:  2017-01-06       Impact factor: 5.911

2.  Niemann-Pick C2 protein expression regulates lithogenic diet-induced gallstone formation and dietary cholesterol metabolism in mice.

Authors:  Elisa Balboa; Gabriela Morales; Paula Aylwin; Gonzalo Carrasco; Ludwig Amigo; Juan Castro; Attilio Rigotti; Silvana Zanlungo
Journal:  Lipids       Date:  2011-10-30       Impact factor: 1.880

Review 3.  Changes in brain cholesterol metabolome after excitotoxicity.

Authors:  Wei-Yi Ong; Ji-Hyun Kim; Xin He; Peng Chen; Akhlaq A Farooqui; Andrew M Jenner
Journal:  Mol Neurobiol       Date:  2010-02-06       Impact factor: 5.590

4.  Molecular characterization of arylsulfatase G: expression, processing, glycosylation, transport, and activity.

Authors:  Björn Kowalewski; Torben Lübke; Katrin Kollmann; Thomas Braulke; Thomas Reinheckel; Thomas Dierks; Markus Damme
Journal:  J Biol Chem       Date:  2014-08-18       Impact factor: 5.157

5.  Cerebellar alterations and gait defects as therapeutic outcome measures for enzyme replacement therapy in α-mannosidosis.

Authors:  Markus Damme; Stijn Stroobants; Steven U Walkley; Renate Lüllmann-Rauch; Rudi D'Hooge; Jens Fogh; Paul Saftig; Torben Lübke; Judith Blanz
Journal:  J Neuropathol Exp Neurol       Date:  2011-01       Impact factor: 3.685

6.  Lysosomal dysfunction causes neurodegeneration in mucolipidosis II 'knock-in' mice.

Authors:  K Kollmann; M Damme; S Markmann; W Morelle; M Schweizer; I Hermans-Borgmeyer; A K Röchert; S Pohl; T Lübke; J-C Michalski; R Käkelä; S U Walkley; T Braulke
Journal:  Brain       Date:  2012-09       Impact factor: 13.501

Review 7.  Lipid rafts, cholesterol, and the brain.

Authors:  Zeljka Korade; Anne K Kenworthy
Journal:  Neuropharmacology       Date:  2008-03-14       Impact factor: 5.250

Review 8.  Do GWAS and studies of heterozygotes for NPC1 and/or NPC2 explain why NPC disease cases are so rare?

Authors:  Robert P Erickson
Journal:  J Appl Genet       Date:  2018-09-13       Impact factor: 3.240

Review 9.  Cholesterol metabolism and homeostasis in the brain.

Authors:  Juan Zhang; Qiang Liu
Journal:  Protein Cell       Date:  2015-02-15       Impact factor: 14.870

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.